Published in Clin Obstet Gynaecol on December 01, 1980
Gas-liquid chromatographic determination of theophylline in human plasma. J Chromatogr (1975) 1.54
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci (1991) 1.05
MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1989) 0.99
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1990) 0.98
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 0.90
Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. Eur J Pharmacol (1992) 0.90
MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B. J Neurochem (1984) 0.84
Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships. J Med Chem (1985) 0.84
Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. J Neurochem (1985) 0.83
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential. J Neural Transm Suppl (1994) 0.80
Resin activation capture technology: libraries from stabilized acyl-pyridinium on solid support. Biotechnol Bioeng (2000) 0.80
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1999) 0.79
3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. J Med Chem (1990) 0.79
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site. J Med Chem (1992) 0.79
Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds. Biochem Pharmacol (1987) 0.78
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site. J Pharmacol Exp Ther (1992) 0.78
Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharm Acta Helv (2000) 0.77
Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor. J Med Chem (1994) 0.77
(E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase. J Med Chem (1984) 0.77
MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease. J Neural Transm Suppl (1993) 0.77
Design and early clinical evaluation of selective inhibitors of monoamine oxidase. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.77
Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J Pharmacol Exp Ther (1997) 0.76
The rational design of suicide substrates of amine oxidases. Biochem Soc Trans (1986) 0.76
Electronic record linkage to create diabetes registers. Impressive results can be obtained without record linkage. BMJ (1998) 0.75
Secondary haemorrhage from the ovarian blood vessels--a case report. Aust N Z J Obstet Gynaecol (1965) 0.75
Chromosome damage and sister chromatid exchanges in lymphocyte cultures from patients with two primary cancers. Cancer Genet Cytogenet (1985) 0.75
Electroejaculation of the paraplegic male followed by pregnancy. Med J Aust (1975) 0.75
Extraction procedures for some common drugs in clinical and forensic toxicology. J Forensic Sci (1976) 0.75
Incompetence of the cervix. Aust N Z J Obstet Gynaecol (1978) 0.75
Single dose tinidazole prophylaxis in hysterectomy. Aust N Z J Obstet Gynaecol (1985) 0.75
(Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B. Biochem Pharmacol (1986) 0.75
Conformationally restricted analogues of nicotine and anabasine. Bioorg Med Chem Lett (1998) 0.75
Modeling of competitive phosphono amino acid NMDA receptor antagonists. J Med Chem (1992) 0.75
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain. J Steroid Biochem Mol Biol (1996) 0.75
John Kenneth Gabriel. Med J Aust (1977) 0.75
Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase. J Med Chem (1994) 0.75
A view of education in obstetrics and gynecology. Med J Aust (1969) 0.75
Naegele's pelvis. Med J Aust (1966) 0.75
Dermahesive: a new concept in surgical dressings. Med J Aust (1977) 0.75
4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex. J Med Chem (1990) 0.75
Planned pregnancy in a patient who was receiving home parenteral nutrition. Med J Aust (1987) 0.75
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex. J Med Chem (1990) 0.75